Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19
Clinical trial NCT04315298 · COMPLETED
Trial details
- NCT number
- NCT04315298
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-18
- Primary completion
- 2020-07-24
- Enrollment
- 1912
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.